Published in Br J Cancer on February 07, 2012
Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease. Breast Cancer Res (2016) 0.84
Impact of targeting insulin-like growth factor signaling in head and neck cancers. Growth Horm IGF Res (2013) 0.84
Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based Proteomics. PLoS One (2016) 0.79
Epidemiology and Inherited Predisposition for Sporadic Pancreatic Adenocarcinoma. Hematol Oncol Clin North Am (2015) 0.77
Understanding the Key to Targeting the IGF Axis in Cancer: A Biomarker Assessment. Front Oncol (2015) 0.76
Expression of insulin-like growth factor family genes in clear cell renal cell carcinoma. Contemp Oncol (Pozn) (2016) 0.75
Correlation between insulin‑like growth factor binding protein 3 and metastasis‑associated gene 1 protein in esophageal squamous cell carcinoma. Mol Med Rep (2016) 0.75
Serum Insulin-Like Growth Factor Axis and the Risk of Pancreatic Cancer: Systematic Review and Meta-Analysis. Nutrients (2017) 0.75
Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer (2010) 10.61
Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev (1995) 9.54
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet (2004) 8.77
Fasting serum glucose level and cancer risk in Korean men and women. JAMA (2005) 6.69
Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science (1998) 6.50
Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev (2002) 6.43
Insulin-like growth factors and neoplasia. Nat Rev Cancer (2004) 6.29
Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer (2005) 6.06
The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol (1997) 4.73
Abnormal glucose metabolism and pancreatic cancer mortality. JAMA (2000) 4.01
Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol (2010) 3.75
The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev (2000) 3.01
Prospective study of hyperglycemia and cancer risk. Diabetes Care (2007) 2.89
Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA (2005) 2.71
Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc Nutr Soc (2001) 2.68
Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol (2000) 2.47
Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism. J Biol Chem (1997) 2.44
Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med (2008) 2.33
Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr (2002) 2.25
Epidemiology of insulin-like growth factor-I in elderly men and women. The Rancho Bernardo Study. Am J Epidemiol (1997) 2.06
A meta-analysis of obesity and the risk of pancreatic cancer. Br J Cancer (2003) 2.02
Insulin-like growth factor binding protein-1: recent findings and new directions. Proc Soc Exp Biol Med (1997) 2.00
Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. Cancer Res (1995) 1.89
Diabetes status and post-load plasma glucose concentration in relation to site-specific cancer mortality: findings from the original Whitehall study. Cancer Causes Control (2004) 1.74
Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays. Cancer Epidemiol Biomarkers Prev (2005) 1.67
Pilot phase studies on the accuracy of dietary intake measurements in the EPIC project: overall evaluation of results. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol (1997) 1.51
Epidemiology and prevention of pancreatic cancer. Jpn J Clin Oncol (2004) 1.46
Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies. Int J Cancer (2010) 1.40
Insulin-like growth factor I and transforming growth factor alpha as autocrine growth factors in human pancreatic cancer cell growth. Cancer Res (1990) 1.38
Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer. Int J Cancer (2004) 1.33
Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohorts. Cancer Causes Control (2010) 1.21
Insulin-like growth factor binding protein-3 mediates tumor necrosis factor-alpha-induced apoptosis: role of Bcl-2 phosphorylation. Cell Growth Differ (2002) 1.11
Serum insulin-like growth factor-I, insulin-like growth factor binding protein-3, and the risk of pancreatic cancer death. Int J Cancer (2004) 1.10
Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Diabetologia (2011) 1.08
Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev (2010) 1.07
IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1/PI3K/Akt signaling pathway in pancreatic cancer cells. J Surg Res (2008) 1.07
Serum and tissue level of insulin-like growth factor-I (IGF-I) and IGF-I binding proteins as an index of pancreatitis and pancreatic cancer. Int J Exp Pathol (2002) 1.06
Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts. Br J Cancer (2007) 1.01
Insulin-like growth factor (IGF)-1, IGF-binding protein-3, and pancreatic cancer in male smokers. Cancer Epidemiol Biomarkers Prev (2004) 1.00
Serum levels of insulin-like growth factors (IGF-I and IGF-II) and their binding protein (IGFBP-3) are not elevated in pancreatic cancer. Int J Pancreatol (1997) 0.83
Correspondence re: Giovannucci et al., A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol. Biomark. Prev., 9: 345-349, 2000. Cancer Epidemiol Biomarkers Prev (2001) 0.78
Regulation of prostate cell growth by the insulin-like growth factor binding proteins and their proteases. Endocrine (1997) 0.78
An STS-based map of the human genome. Science (1995) 17.72
General and abdominal adiposity and risk of death in Europe. N Engl J Med (2008) 14.49
Design and serendipity in establishing a large cohort with wide dietary intake distributions : the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol (2001) 11.17
Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet (1998) 10.11
European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr (2002) 8.77
Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature (1997) 7.33
Active and passive smoking and pathological indicators of lung cancer risk in an autopsy study. JAMA (1992) 6.56
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases. Virology (1995) 5.34
Endemic cholera in rural Bangladesh, 1966-1980. Am J Epidemiol (1982) 4.93
The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol (1997) 4.73
Mediterranean diet pyramid: a cultural model for healthy eating. Am J Clin Nutr (1995) 4.50
Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems. J Virol (1999) 4.32
A case-control study of the efficacy of a non-randomized breast cancer screening program in Florence (Italy). Int J Cancer (1986) 4.11
Exclusive breastfeeding reduces acute respiratory infection and diarrhea deaths among infants in Dhaka slums. Pediatrics (2001) 4.05
Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metab Res Rev (2000) 4.01
Interventions to prevent weight gain: a systematic review of psychological models and behaviour change methods. Int J Obes Relat Metab Disord (2000) 3.90
Reliability and validity of the combined heart rate and movement sensor Actiheart. Eur J Clin Nutr (2005) 3.84
The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening. Int J Obes Relat Metab Disord (2000) 3.83
Multicenter case-control study of exposure to environmental tobacco smoke and lung cancer in Europe. J Natl Cancer Inst (1998) 3.74
Diet and overall survival in elderly people. BMJ (1995) 3.73
Population based cohort study of the association between alcohol intake and cancer of the upper digestive tract. BMJ (1998) 3.63
Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst (2000) 3.57
Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst (2000) 3.55
Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev (2001) 3.43
Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centres. Int J Epidemiol (1997) 3.39
Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut (2003) 3.30
Daptomycin disrupts membrane potential in growing Staphylococcus aureus. Antimicrob Agents Chemother (1991) 3.18
Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol (2000) 3.13
Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst (1998) 3.10
The impact of including husbands in antenatal health education services on maternal health practices in urban Nepal: results from a randomized controlled trial. Health Educ Res (2006) 3.10
Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and dioxins. An expanded and updated international cohort study. Am J Epidemiol (1997) 3.10
Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer (2005) 3.04
Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB. Neurology (2010) 2.92
The detection of gene-environment interaction for continuous traits: should we deal with measurement error by bigger studies or better measurement? Int J Epidemiol (2003) 2.89
Characterization of vancomycin resistance in Enterococcus faecium and Enterococcus faecalis. Antimicrob Agents Chemother (1989) 2.83
Waterborne outbreak of rotavirus diarrhoea in adults in China caused by a novel rotavirus. Lancet (1984) 2.82
Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran. Br J Cancer (2008) 2.79
Functional food science and gastrointestinal physiology and function. Br J Nutr (1998) 2.78
Television viewing and low participation in vigorous recreation are independently associated with obesity and markers of cardiovascular disease risk: EPIC-Norfolk population-based study. Eur J Clin Nutr (2003) 2.68
Ecological genomics of marine Roseobacters. Appl Environ Microbiol (2007) 2.68
Exposure of humans to ambient levels of ozone for 6.6 hours causes cellular and biochemical changes in the lung. Am J Respir Cell Mol Biol (1991) 2.67
Residential area deprivation predicts smoking habit independently of individual educational level and occupational social class. A cross sectional study in the Norfolk cohort of the European Investigation into Cancer (EPIC-Norfolk). J Epidemiol Community Health (2003) 2.66
Longitudinal studies of infectious diseases and physical growth of children in rural Bangladesh. II. Incidence of diarrhea and association with known pathogens. Am J Epidemiol (1982) 2.65
Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care (2000) 2.63
Comparison of nutrients in the food composition tables available in the nine European countries participating in EPIC. European Prospective Investigation into Cancer and Nutrition. Eur J Clin Nutr (1999) 2.63
A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer (2005) 2.62
Purpura of the ears: a distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children. Br J Dermatol (1999) 2.58
Type of alcohol consumed and mortality from all causes, coronary heart disease, and cancer. Ann Intern Med (2000) 2.57
The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion. Diabet Med (1995) 2.56
Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials. Diabetologia (2012) 2.53
Adherence induces selective mRNA expression of monocyte mediators and proto-oncogenes. J Immunol (1988) 2.52
Small supernumerary marker chromosomes--progress towards a genotype-phenotype correlation. Cytogenet Genome Res (2006) 2.52
Effect of alcohol consumption on systemic markers of inflammation. Lancet (2001) 2.52
Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia (2011) 2.43